Therapeutic effect of everolimus (RAD001) in combination with antiangiogenic chemotherapy for gastric cancer in vivo

被引：1
|
作者：
Cejka, D.
Preusser, M.
Sieghart, W.
Strommer, S.
Werzowa, J.
Fuereder, T.
Wacheck, V.
机构：
[1] Med Univ Vienna, Div Expt Oncol On, Vienna, Austria
[2] Med Univ Vienna, Inst Neurol, Vienna, Austria
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70075-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
69
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [1] Inhibition of HIF-1α by RAD001 (everolimus) in combination with antiangiogenic chemotherapy in a gastric cancer model
    Cejka, D.
    Preusser, M.
    Sieghart, W.
    Strommer, S.
    Werzowa, J.
    Fuereder, T.
    Wacheck, V.
    PHARMACOLOGY, 2006, 78 (03) : 153 - 153
  • [2] Adrenocortical Cancer: A Therapeutic Approach with Everolimus (RAD001)
    Gueorguiev, M.
    Bhattacharya, S.
    Grossman, A.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 33 - 33
  • [3] RAD001 (everolimus)
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2008, 19 : 21 - 22
  • [4] Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients
    Su Jin Lee
    Jongtae Lee
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Kyoung-Mee Kim
    In-Gu Do
    Sin-Ho Jung
    Dong-Seok Yim
    Won Ki Kang
    Investigational New Drugs, 2013, 31 : 1580 - 1586
  • [5] Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients
    Lee, Su Jin
    Lee, Jongtae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kim, Kyoung-Mee
    Do, In-Gu
    Jung, Sin-Ho
    Yim, Dong-Seok
    Kang, Won Ki
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1580 - 1586
  • [6] Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination
    Fumiko Taguchi
    Yasuo Kodera
    Yasufumi Katanasaka
    Kazuyoshi Yanagihara
    Tomohide Tamura
    Fumiaki Koizumi
    Investigational New Drugs, 2011, 29 : 1198 - 1205
  • [7] Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination
    Taguchi, Fumiko
    Kodera, Yasuo
    Katanasaka, Yasufumi
    Yanagihara, Kazuyoshi
    Tamura, Tomohide
    Koizumi, Fumiaki
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1198 - 1205
  • [8] Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancer
    Manegold, Philipp C.
    Paringer, Carmen
    Kulka, Ulrike
    Krimmel, Klaus
    Eichhorn, Martin E.
    Wilkowski, Ralf
    Jauch, Karl-Walter
    Guba, Markus
    Bruns, Christiane J.
    CLINICAL CANCER RESEARCH, 2008, 14 (03) : 892 - 900
  • [9] Combination of antiangiogenic RAD001 and ionizing radiation in therapy of malignant tumors
    Manegold, Philipp
    Paringer, Carmen
    Kulka, Ulrike
    Wilkowski, Ralf
    Jauch, Karl-Walter
    Guba, Markus
    Bruns, Christiane J.
    CANCER RESEARCH, 2006, 66 (08)
  • [10] Combination of antiangiogenic therapy using the mTOR inhibitor RAD001 (everolimus) and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: Dose-finding study
    Joka, Mareile
    Boeck, Stefan Hubert
    Hosius, Christian
    Decroix, Laetitia
    May, Christoph
    Alberter, Barbara
    Pustowka, Anette
    Heinemann, Volker
    Bruns, Christiane
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345